|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.15 CNY | +3.62% |
|
+2.79% | -27.67% |
Beijing Beilu Pharmaceutical Co., Ltd reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 349.21 million compared to CNY 534.19 million a year ago. Revenue was CNY 351.26 million compared to CNY 535.28 million a year ago.
Net income was CNY 40 million compared to CNY 116.48 million a year ago. Basic earnings per share from continuing operations was CNY 0.08 compared to CNY 0.24 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -27.67% | 350M | |
| +40.73% | 739B | |
| +32.83% | 598B | |
| -6.30% | 353B | |
| +15.15% | 318B | |
| +4.05% | 285B | |
| +15.00% | 240B | |
| -5.52% | 206B | |
| +6.17% | 164B | |
| -0.45% | 162B |
BEIJING BEILU PHARMACEUTICAL CO., LTD 
